PTM can mediate NAFLD development by affecting oxidative stress, lactate accumulation, autophagy, insulin resistance, and inflammation, and the major signaling pathways affected include PPAR, AMPK, AKT, and JAK2–STAT3. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.